StocksTelegraph
S&P 500—NASDAQ—DOW—RUSSELL—
NASDAQ · SCLX·Healthcare

Scilex Holding Company Stock Analysis & AI Score

Scilex Holding Company (SCLX) has an ST Score of 38.3 (C), driven by its Valuation (A) and held back by its Momentum (F). Analysts rate it Buy.

Market Closed
$4.94
Prev Close
—
Market Cap
—
Day Range
—
52W Range
—
P/E
—
EPS (TTM)
—
Volume
—
Avg —
Beta
—
38
ST Score
38.3/100C

Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.

As of
AI Daily Briefing
Analysis by AI
Price History
—
Technical Indicators
FMP
Earnings Surprises
Analyst Forecast
Revenue Mix

Company Information

Employees—
CEO—
SectorHealthcare
IndustryDrug Manufacturers - General
IPO Date—
Website—
Country—
ExchangeNASDAQ

SEC Filings

Annual Report (10-K)

Filing DateAcceptedLink
Loading…

Quarterly Report (10-Q)

Filing DateAcceptedLink
Loading…
Analyst Price Target
ESG Score
Latest News

ST Score

SCLX
38.3out of 100
Grade C

Scilex Holding Company (SCLX) has an ST Score of 38.3 (C), driven by its Valuation (A) and held back by its Momentum (F). Analysts rate it Buy.

Strongest
ValuationA
Weakest
MomentumF
All factor grades
  • ValuationA
  • GrowthC+
  • ProfitabilityC
  • Financial StrengthC
  • MomentumF
  • Piotroski2/9
Score methodology
Press Releases

Contact

SCLX stock: frequently asked questions

What is SCLX's ST Score?

Scilex Holding Company (SCLX) has an ST Score of 38.3 (C), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.

Is SCLX a buy, hold, or sell?

Analysts rate SCLX a Buy. Our ST Score grades it C (38.3/100). The ST Score is a data-driven signal, not a recommendation.

What are SCLX's factor grades?

Valuation A, Profitability C, Financial Strength C, Momentum F, Growth C+.

What is SCLX's valuation grade?

Scilex Holding Company (SCLX) earns a valuation grade of A, measured against Drug Manufacturers - General peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.

What is SCLX's growth grade?

Scilex Holding Company (SCLX) earns a growth grade of C+, measured against Drug Manufacturers - General peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.

What is SCLX's profitability grade?

Scilex Holding Company (SCLX) earns a profitability grade of C, measured against Drug Manufacturers - General peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.

What is SCLX's financial strength grade?

Scilex Holding Company (SCLX) earns a financial strength grade of C, measured against Drug Manufacturers - General peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.

What is SCLX's Piotroski score?

Scilex Holding Company (SCLX) has a Piotroski F-Score of 2 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.